To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation

Chronic Respiratory Disease

Volumn 3, Issue 1, 2006, Pages 39-47

  Dobbels, Fabienne ^a,b   Verleden, G ^b   Dupont, L ^b   Vanhaecke, J ^b   De Geest, S ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Behaviour; Pretransplant screening; Psychological; Review; Selection criteria

Indexed keywords

EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH BEHAVIOR; HUMAN; LIFE EXPECTANCY; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MORTALITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SCREENING; SOCIAL PSYCHOLOGY; SURVIVAL;

ALCOHOLISM; HEALTH BEHAVIOR; HUMANS; LUNG TRANSPLANTATION; MENTAL DISORDERS; MENTAL HEALTH; PATIENT COMPLIANCE; PATIENT SELECTION; SELF CARE; SMOKING CESSATION; SOCIAL SUPPORT;

EID: 32444449853     PISSN: 14799723     EISSN: None     Source Type: Journal    
DOI: 10.1191/1479972306cd082ra     Document Type: Review

References (97)

1. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986; 314: 1140-45.
2. MacNaughton KL, Rodrigue JR, Cicale M, Staples EM. Health-related quality of life and symptoms frequency before and after lung transplantation. Clin Transplant 1998; 12: 320-23.
3. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998; 113: 633-44.
4. Corris PA. Lung transplantation for chronic obstructive pulmonary disease: an exercise in quality rather than quantity? Thorax 1999; 54(Suppl 2): S24-S27.
5. Lanuza DM, McCabe M, Norton-Rosko M, Corliss JW, Garrity E. Symptom experiences of lung transplant recipients: comparisons across gender, pretransplantation diagnosis, and type of transplantation. Heart Lung 1999; 28: 429-37.
6. De Vito Dabbs A, Dew MA, Stilley CS et al. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003; 22: 1268-75.
7. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult lung and heart-lung transplant report - 2004. J Heart Lung Transplant 2004; 23: 804-15.
8. Smith CM. Patient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med 1997; 18: 183-97.
9. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E Jr. Prospective study of functional status and quality of life before and after lung transplantation (LTX). Chest 2000; 118: 115-22.
10. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. Transplantation 1998; 66: 951-56.
11. Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J 2003; 22: 845-52.
12. Yu AD, Garrity ER. Lung transplantation: Recipient selection. Chest Surg Clin N Am 2003; 13: 405-28.
13. Egan TM. Ethical issues in thoracic organ distribution for transplant. Am J Transplant 2003; 3: 366-72.
14. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20: 518-24.
15. De Meester J, Smits JM, Persijn GG, Haverich A. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 1999; 18: 563-71.
16. Manzetti JD, Hoffman LA, Sereika SM, Sciurba FC, Griffith BP. Exercise, education, and quality of life in lung transplant candidates. J Heart Lung Transplant 1994; 13: 297-305.
17. Arcasoy SM, Kotloff RM. Lung transplantation. N Eng J Med 1999; 340: 1081-91.
18. TenVergert EM, Vermeulen KM, Geertsma A et al. Quality of life before and after lung transplantation in patients with emphysema versus other indications. Psychol Rep 2001; 89: 707-17.
19. Force SD, Choong C, Meyers BF. Lung transplantation for emphysema. Chest Surg Clin N Am 2003; 13: 651-67.
20. Craven JL, Bright J, Dear CL. Psychiatric, psychosocial and rehabilitative aspects of lung transplantation. Clin Chest Med 1990; 11: 247-57.
21. Smolin TL, Aguiar LJ. Psychosocial and financial aspects of lung transplantation. Crit Care Nurs Clin North Am 1996; 8: 293-303.
22. Ochoa LL, Richardson GW. The current status of lung transplantation: a nursing perspective. AACN Clin Issues 1999; 10: 229-39.
23. Steinman TI, Becker BN, Frost AE et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001; 71: 1189-204.
24. Parekh PI, Blumenthal JA, Babyak MA et al. for the INSPIRE Investigators. Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest 2003; 124: 1682-88.
25. Olbrisch ME, Levenson JL. Psychosocial assessment of organ transplant candidates. Current status of methodological and philosophical issues. Psychosomatics 1995; 36: 236-43.
26. Chacko RC, Harper RG, Kunik M, Young J. Relationship of psychiatric morbidity and psychosocial factors in organ transplant candidates. Psychosomatics 1996; 37: 100-107.
27. Woodman CL, Geist LJ, Vance S, Laxson C, Jones K, Kline JN. Psychiatric disorders and survival after lung transplantation. Psychosomatics 1999; 40: 293-97.
28. Dobbels F, De Geest S, Cleemput I et al. Psychosocial and behavioral selection criteria for solid organ transplantation. Prog Transplant 2001; 11: 121-32.
29. Pinson CW, Feurer ID, Payne JL, Wise PE, Shockley S, Speroff T. Health-related quality of life after different types of solid organ transplantation. Ann Surg 2000; 232: 597-607.
30. Cicutto L, Braidy C, Moloney S, Hutcheon M, Holness DL, Downey GP. Factors affecting attainment of paid employment after lung transplantation. J Heart Lung Transplant 2004; 23: 481-86.
31. Lanuza DM, McCabe MA. Care before and after lung transplant and quality of life research. AACN Clin Issues 2001; 12: 186-201.
32. Burker EJ, Carels RA, Thompson LF, Rodgers L, Egan T. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr Pulmonol 2000; 30: 453-60.
33. Limbos MM, Chan CK, Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997; 112: 1165-74.
34. Limbos MM, Joyce DP, Chan CKN, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000; 118: 408-16.
35. Trumper A, Appleby L. Psychiatric morbidity in patients undergoing heart, heart and lung, or lung transplantation. J Psychosom Res 2001; 50: 103-105.
36. Myaskovsky L, Dew MA, Switzer GE et al. Avoidant coping with health problems is related to poorer quality of life among lung transplant candidates. Prog Transplant 2003; 13: 183-92.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
38. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 1996; 168 (Suppl): 17-30.
39. Squier HC, Ries AL, Kaplan RM et al. Quality of well-being predicts survival in lung transplantation candidates. Am J Respir Crit Care Med 1995; 152: 2032-36.
40. Stilley CS, Miller DJ, Manzetti JD, Marino IR, Keenan RJ. Optimism and coping styles: a comparison of candidates for liver transplantation with candidates for lung transplantation. Psychother Psychosom 1999; 68: 299-303.
41. Vermeulen KM, Ouwens JP, van der Bij W, de Boer WJ, Koeter GH, TenVergert EM. Long-term quality of life in patients surviving at least 55 months after lung transplantation. Gen Hosp Psychiatry 2003; 25: 95-102.
42. Van den Berg JW, Geertsma A, van der Bij W et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000; 161: 1937-41.
43. Eaton WW. Progress in the epidemiology of anxiety disorders. Epidemiol Rev 1995; 17: 32-38.
44. Katz R, Stephen J, Shaw BF, Matthew A, Newman F, Rosenbluth M. The East York Health Needs Study. I: prevalence of DSM-III-R psychiatric disorder in a sample of Candian women. Br J Psychiatry 1995; 166: 100-106.
45. Brawman-Mintzer O, Lydiard RB. Generalized anxiety disorders: issues in epidemiology. J Clin Psychiatry 1996; 57(Suppl 7): 3-8.
46. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: A longitudinal study. Chest 1998; 113: 358-64.
47. Hodges B, Craven J, Littlefield C. Bibliotherapy for psychosocial distress in lung transplant patients and their families. Psychosomatics 1995; 36: 360-68.
48. Caine N, Sharpies LD, Dennis C, Higenbottam TW, Wallwork J. Measurement of health-related quality of life before and after heart-lung transplantation. J Heart Lung Transplant 1996; 15: 1047-58.
49. Stavem K, Bjortuft O, Lund MB, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000; 67: 159-65.
50. Dobbels F, Put C, Vanhaecke J. Personality disorders: a challenge for transplantation. Prog Transplant 2000; 10: 226-32.
51. Chesler BE, Hsu LK. Development of an eating disorder in a 40 year-old male lung transplant candidate: a case study. Int J Eat Disord 1995; 17: 205-09.
52. Singer HK, Ruchinskas RA, Riley KC, Broshek DK, Barth JT. The psychological impact of end-stage lung disease. Chest 2001; 120: 1246-52.
53. Crews WD Jr, Jefferson AL, Broshek DK et al. Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation. Arch Clin Neuropsychol 2003; 18: 353-62.
54. Crews WD, Jefferson AL, Bolduc T et al. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 2001; 16: 643-52.
55. Liesker JJ, Postma DS, Beukema RJ et al. Cognitive performance in patients with COPD. Respir Med 2004; 98: 351-56.
56. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and noctural oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1983; 143: 1941-47.
57. Bashir RM. Neurologic complications of organ transplantation. Curr Treat Options Neurol 2001; 3: 543-54.
58. Knower MT, Pethke SD, Valentine VG. Reversible cortical blindness after lung transplantation. South Med J 2003; 96: 606-12.
59. Sarason BR, Sarason IG, Pierce GR. Differentiating the cognitive and behavioral aspects of social support. In Sarason BR ed. Social support: an interactional view. New York, John Wiley & Sons Inc, 1990: 267-96.
60. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004; 23: 207-18.
61. Dew MA, Simmons RG, Roth LH et al. Psychosocial predictors of vulnerability to distress in the year following heart transplantation. Psychol Med 1994; 24: 929-45.
62. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996; 15: 631-45.
63. Lazaro L, Marcos T, Valdes M. Affective disorders, social support, and health status in geriatric patients in a general hospital. Gen Hosp Psychiatry 1995; 17: 299-304.
64. Aaronson LS. Perceived and received support: effects on health behavior during pregnancy. Nurs Res 1989; 38: 4-9.
65. Levy RL. Social support and compliance: update. J Hypertens 1985; 3(Suppl 1): S45-S49.
66. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994; 8: 550-57.
67. Bunzel B, Wollenek G. Heart transplantation: Are there psychosocial predictors for clinical success of surgery? Thorac Cardiovasc Surg 1994; 42: 103-107.
68. Bunzel B, Laederach-Hoffmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation 2000; 70: 711-16.
69. Sabate E. World health organization report: adherence to long-term therapies. Evidence for action. Switzerland: World Health Organization, 2003.
70. Teichman BJ, Burker EJ, Weiner M, Egan TM. Factors associated with adherence to treatment regimens after lung transplantation. Prog Transplant 2000; 10: 112-21.
71. Matthees BJ, Anantachoti P, Kreitzer MJ, Savik K, Hertz MI, Gross CR. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung 2001; 30: 258-68.
72. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549-62.
73. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565-70.
74. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-13.
75. Dobbels F, De Geest S, Van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication noncompliance on subsequent outcome after heart transplantation: a five years follow-up. J Heart Lung Transplant 2004; 23: 1245-51.
76. Beresford TP. Predictive factors for alcoholic relapse in the selection of alcohol-dependent persons for hepatic transplant. Liver Transpl Surg 1997; 3: 280-91.
77. Keeffe EB. Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome, and recidivism. Liver Transpl Surg 1996; 2 (Suppl 1): 12-20.
78. Merikangas KR, Gelernter CS. Comorbidity for alcoholism and depression. Psychiatr Clin North Am 1990; 13: 613-32.
79. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511-18.
80. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995; 39: 197-206.
81. Schuckit MA, Tipp JE, Smith TL et al. An evaluation of type A and B alcoholics. Addiction 1995; 90: 1189-203.
82. Charness ME. Brain lesions in alcoholics. Alcohol Clin Exp Res 1993; 17: 2-11.
83. Nagele H, Kalmar P, Rodiger W, Stubbe AM. Smoking after heart transplantation: an underestimated hazard? Eur J Cardiothorac Surg 1997; 12: 70-74.
84. Hojo M, Morimoto T, Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530-34.
85. Keeffe EB, Gettys C, Esquivel CO. Liver transplantation in patients with severe obesity. Transplantation 1994; 57: 309-11.
86. Modlin CS, Flechner SM, Goormastic M et al. Should obese patients lose weight before receiving a kidney transplant? Transplantation 1997; 64: 599-604.
87. Grady KL, Costanzo MR, Fisher S, Koch D. Preoperative obesity is associated with decreased survival after heart transplantation. J Heart Lung Transplant 1996; 15: 863-71.
88. Halme L, Eklund B, Kyllonen L, Salmela K. Is obesity still a risk factor in renal transplantation? Transplant Int 1997; 10: 284-88.
89. Mullan B, Snyder M, Lindgren B, Finkelstein SM, Hertz MI. Home monitoring for lung transplant candidates. Prog Transplant 2003; 13: 176-82.
90. Bjortuft O, Johansen B, Boe J, Foerster A, Holter E, Geiran O. Daily home spirometry facilitates early detection of rejection in single lung transplant recipients with emphysema. Eur Respir J 1993; 6: 705-708.
91. Finkelstein SM, Lindgren B, Prasad B et al. Reliability and validity of spirometry measurements in a paperless home monitoring dairy program for lung transplantation. Heart Lung 1993; 22: 523-33.
92. Chlan L, Snyder M, Finkelstein S et al. Promoting adherence to an electronic home spirometry research program after lung transplantation. Appl Nurs Res 1998; 11: 36-40.
93. Morlion B, Verbandt Y, Paiva M et al. A telemanagement system for home follow-up of respiratory patients. IEEE Eng Med Biol Mag 1999; 18: 71-79.
94. Lindgren BR, Snyder M, Sabati N, Adam T, Pieczkiewicz D, Finkelstein SM. Health locus of control and adherence with home spirometry use in lung transplant recipients. Prog Transplant 2002; 12: 24-29.
95. Sabati N, Snyder M, Edin-Stibbe C, Lindgren B, Finkelstein S. Facilitators and barriers to adherence with home monitoring using electronic spirometry. AACN Clin Issues 2001; 12: 178-85.
96. Morlion B, Knoop C, Paiva M, Estenne M. Internet-based home monitoring of pulmonary function after lung transplantation. Am J Respir Crit Care Med 2002; 165: 694-97.
97. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296-310.